LM, do you know the criteria for this trial?
I think I found the documentation here : clinicaltrials.gov/ct2/show/NCT01940471
If this IS the trial, note that it is a double blind study, which means some will get the drugs and neither the docsor patients know who is getting the drugs and who is getting the placebo. And it is long...did you know that?
I ask becasue Mike was all set up for a Giliad trial in January and then at the last moment, on the day we went to pick up the pills, they told us that they couldn't let him start because he didn't meet one of the criteria for the "arm" of the study they were doing...he was to be in the POST TRANSPLANT, genotype 1a, with high Hep C Viral load post TP, WITH cirrhosis. They assumed he HAD cirrhosis because of his liver biopsy and his bloods, but when they did the Fibroscan a the last moment, it came out Stage 3 Fibrosis, NO cirrhosis...so we were so very disappointed. If we had better understood the trial documentation, we would have known better that all that testing is to make sure you meet all the criteria they are measuring.
In his case, it was a late study, so not double blind...everyone knew everything...docs and patients.
the same time, he got prescribed the medication from his Hep for a regular Hep C treatment (Olysio and Sovaldi) and it was covered by his insurance, so he is doing that now...Sovaldi and Olysio.
I hope all is well for your starting right away and for responding positively to the meds.
MamaLama, Forum moderator - Hepatitis
Partner received liver transplant May 1, 2011, FL
Began Hep C Treatment: Sovaldi/Olysio March 3, 2014
Beginning Viral Load = 3,700,000
Week 1 Viral Load = 302
Week 2 Viral Load = 36
Week 3 Viral Load = <15 Detected
Week 4 Viral Load = <15 Undetected
Post Edited (MamaLama) : 4/11/2014 9:16:19 AM (GMT-6)